hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct removal of disease-causing substances from the blood stream of a patient. The technology targets a broad range of harmful compounds such as toxins, pathogenic organisms, or overdosed drugs. Moreover, by being more targeted, efficient, and gentler than previous blood filters, we outperform state of the art therapies and improve patient outcomes.
Our first development candidate focuses on sepsis, a blood spread infection with so far only very limited treatment options.

News

15.11.2022 Swiss startups get global exposure (startupticker.ch)
07.04.2022 Swiss Economic Award: Das sind die Finalisten (startupticker.ch)
10.03.2022 Fourteen Swiss startups ready for scaling (startupticker.ch)
09.06.2021 First Venture Leaders Medtech selected (startupticker.ch)

Milestones/News

Videos and Presentations


hemotune - Restoring immune balance in sepsis